Biofrontera Inc. Profile Avatar - Palmy Investing

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in co…

Drug Manufacturers - Specialty & Generic
US, Woburn [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Biofrontera Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of BFRI's Analysis
CIK: 1858685 CUSIP: 09077D100 ISIN: US09077D2099 LEI: - UEI: -
Secondary Listings
BFRI has no secondary listings inside our databases.